Does TOFACITINIB Cause Exposure during pregnancy? 1,489 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,489 reports of Exposure during pregnancy have been filed in association with TOFACITINIB (XELJANZ XR). This represents 1.0% of all adverse event reports for TOFACITINIB.
1,489
Reports of Exposure during pregnancy with TOFACITINIB
1.0%
of all TOFACITINIB reports
650
Deaths
761
Hospitalizations
How Dangerous Is Exposure during pregnancy From TOFACITINIB?
Of the 1,489 reports, 650 (43.7%) resulted in death, 761 (51.1%) required hospitalization, and 809 (54.3%) were considered life-threatening.
Is Exposure during pregnancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 1,489 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Exposure during pregnancy?
ADALIMUMAB (4,556)
ACETAMINOPHEN (4,395)
INFLIXIMAB (3,636)
PREDNISONE (2,906)
HYDROXYCHLOROQUINE (2,610)
RITUXIMAB (2,468)
CETIRIZINE (2,435)
TOCILIZUMAB (2,342)
FOLIC ACID (2,318)
LEFLUNOMIDE (2,264)
Which TOFACITINIB Alternatives Have Lower Exposure during pregnancy Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN